ClinicalTrials.Veeva

Menu

Treatment of Adolescent Suicide Attempters (TASA)

N

New York State Psychiatric Institute

Status and phase

Completed
Phase 3
Phase 2

Conditions

Suicide, Attempted
Depression

Treatments

Drug: citalopram
Behavioral: Cognitive Behavioral Therapy
Drug: bupropion
Drug: escitalopram
Drug: lithium
Drug: mirtazapine
Drug: venlafaxine
Drug: fluoxetine
Drug: sertraline

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00080158
DDTR B4-ARD
#4623
U10MH066750 (U.S. NIH Grant/Contract)
U10MH066775 (U.S. NIH Grant/Contract)
U10MH066769 (U.S. NIH Grant/Contract)
U10MH066762 (U.S. NIH Grant/Contract)
U10MH066778 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Full description

Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies.

Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.

Sex

All

Ages

12 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • At least one suicide attempt or interrupted attempt within the past 45 days
  • Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems